GLENCORE PLC ORD USD0.01 (GLEN.L)

Key Updates

Glencore shares have declined a further 2.18% since the 13 August report, falling from $559.40 to $547.20, including a sharp -2.44% drop in the latest session. This marks the third decline in four sessions since the 5 August H1 results release, with the stock now trading well below the post-earnings peak of $573.80 reached on 7 August. News flow was limited to one item — further detail on the planned Sydney depository receipt (DR) listing, confirming an October timeline and framing it as a mechanism to narrow Glencore's valuation discount to peers such as BHP (trading at ~4x tangible book value versus Glencore's <3x, per S&P Capital IQ). No new operational or financial disclosures have emerged since the last report.

Current Trend

Glencore remains up 34.60% YTD and 10.66% over six months, confirming the structural uptrend intact for most of 2026. However, short-term momentum has weakened materially: the stock is now down 1.76% on a 5-day basis despite a positive 1-month return (+5.74%), reflecting a round-trip from the 5 August earnings spike back toward pre-rally levels. The sequence of closes since the H1 report ($573.80 → $560.30 → $571.80 → $559.40 → $547.20) shows a pattern of lower lows, with the $559–560 support zone now broken. The next reference level is the current $547.20 print; a sustained break below this could expose the stock to a retest of levels prevailing before the late-July marketing upgrade. Resistance sits at the $571–574 area, the post-earnings high.

Investment Thesis

The core thesis remains anchored in Glencore's diversified earnings base — physical commodity marketing, copper growth optionality, and energy trading — supported by capital returns ($500m buyback, ~$1bn special distribution) and a structural re-rating catalyst via the Australian listing. The company is executing a multi-year copper expansion (to ~1.6mt by 2035) while trading operations benefited disproportionately from Middle East-driven volatility in H1 2026.

Thesis Status

The fundamental thesis remains intact — no negative operational or financial news has emerged since the last report, and the ASX listing plan continues to progress toward its October target. However, the persistent post-earnings share price erosion (now four consecutive weak sessions out of five) indicates the market has largely priced in the H1 beat and special distribution, with investors booking profits after the initial 3–4% single-day rallies. The thesis is not invalidated, but near-term technical momentum has clearly deteriorated, and the gap between strong fundamentals and weakening price action warrants monitoring for confirmation of a stabilizing base versus further downside.

Key Drivers

The only incremental driver since the last report is confirmation that Glencore's Sydney DR listing will proceed by October, targeting Australia's large pension fund pool without requiring capital raising or full local governance adoption (Financial Times). This follows the broader 5 August catalyst set — record H1 adjusted EBITDA of $10.115bn (+86% YoY), marketing EBIT of $3.3bn, and energy trading EBIT surging 66-fold to $2.66bn on Iran-related disruption (Reuters) — which remain the dominant fundamental backdrop, even as price action has since reversed.

Technical Analysis

Price action shows a clear failure to hold gains above $570, with the stock now testing the lower boundary of its post-earnings trading range. The -2.44% single-day move is the sharpest decline in the recent sequence, suggesting acceleration of selling pressure rather than stabilization. Support at $559–560, which held on 13 August, has now been decisively broken, shifting the near-term technical bias bearish. A close below $547 would open downside toward levels last seen prior to the late-July marketing earnings upgrade. Resistance is defined by the $571–574 post-earnings high; reclaiming this zone would be required to restore short-term bullish momentum. The 1-month (+5.74%) and 6-month (+10.66%) readings remain positive, indicating the medium-term trend has not reversed, but the 1-day and 5-day negative readings signal near-term exhaustion.

Bull Case

• Record H1 2026 results: adjusted EBITDA up 86% YoY to $10.115bn, with marketing adjusted EBIT more than doubling to $3.3bn, the second-highest level on record (Morningstar, Reuters)
• Structural copper growth strategy targeting ~1.6 million tonnes by 2035 (nearly double current output), backed by $4bn net capex in H1 alone, positioning Glencore for long-term demand tailwinds (Reuters)
• Australian secondary listing (targeted October) aims to broaden the investor base, tap A$4.4 trillion pension capital, and narrow Glencore's valuation discount versus peers such as BHP (Financial Times, Financial Times)
• Shareholder returns reinforced via a $500 million share buyback and approximately $1 billion in special cash distributions announced alongside H1 results (Morningstar)
• Energy trading division nearing the top end of full-year EBIT guidance ($3.5bn) after a 66-fold profit surge from Iran-war-driven volatility, with management citing continued market sensitivity to disruption into H2 (Reuters, Bloomberg)

Bear Case

• Persistent post-earnings share price weakness — down in three of the last four sessions and -2.18% since the last report — signals fading momentum and profit-taking despite strong fundamentals, with technical support at $559–560 now broken
• Radiant World provision highlights counterparty risk within Glencore's trading book; while management deems exposure "not material," the firm has ceased new business with the counterparty following similar actions by Vitol and Cargill (Reuters, Bloomberg)
• Ongoing $230 million legal dispute over unpaid oil shipments to an insolvent refinery underscores counterparty and credit risk inherent in physical commodity trading (Bloomberg)
• Outsized H1 energy trading gains are tied to non-recurring geopolitical volatility (Iran conflict, Strait of Hormuz disruption); prior-year energy marketing earnings had already declined for three consecutive years, raising normalization risk into H2/2027 (Reuters)
• Fund managers have expressed skepticism about rapid ASX 200/100 index inclusion given the lack of franking credits, potentially limiting the near-term re-rating benefit of the Australian listing (Reuters)